USANA Health Sciences Inc (USNA)

Payables turnover

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cost of revenue (ttm)	US$ in thousands	425,996	415,397	420,677	427,441	435,517	441,952	448,700	453,182	457,917	470,953	475,733	489,083	498,187	505,416	444,414	362,834	279,609	197,380	188,841	187,661
Payables	US$ in thousands	11,984	7,041	6,648	8,266	10,070	9,321	9,273	10,511	11,049	10,362	10,175	11,248	13,508	13,706	13,144	11,952	18,195	14,173	10,942	11,824
Payables turnover		35.55	59.00	63.28	51.71	43.25	47.41	48.39	43.12	41.44	45.45	46.76	43.48	36.88	36.88	33.81	30.36	15.37	13.93	17.26	15.87

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $425,996K ÷ $11,984K
= 35.55

The payables turnover ratio for USANA Health Sciences Inc has shown an increasing trend over the past few years, indicating that the company is efficiently managing its accounts payable. The ratio increased from 15.87 in March 2020 to 35.55 in December 2024.

A higher payables turnover ratio suggests that the company is paying off its suppliers more frequently, which could indicate good relationships with suppliers or effective inventory management.

However, the ratio experienced fluctuations during the period, which could be due to seasonal variations in purchasing patterns or changes in payment terms with suppliers. It reached its peak at 63.28 in June 2024, indicating a significant improvement in managing payables during that period.

Overall, the increasing trend in payables turnover ratio for USANA Health Sciences Inc is a positive indicator of effective working capital management and efficient utilization of resources.